Axsome Therapeutics, Inc.

US BANCORP \DE\ AXSM

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/30/2026

Shares

130,985

Value ($000)

23,923

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/30/2026	23,923	0.0%	130,985	12/31/2025
2025 Q3	11/12/2025	15,975	0.0%	131,533	9/30/2025
2025 Q2	7/24/2025	13,659	0.0%	130,847	6/30/2025
2025 Q1	5/8/2025	15,196	0.0%	130,295	3/31/2025
2024 Q4	2/5/2025	11,086	0.0%	131,019	12/31/2024
2024 Q3	10/28/2024	11,964	0.0%	133,126	9/30/2024
2024 Q2	8/7/2024	10,683	0.0%	132,705	6/30/2024
2024 Q1	5/8/2024	10,654	0.0%	133,505	3/31/2024
2023 Q4	2/9/2024	11,415	0.0%	143,424	12/31/2023
2023 Q3	11/3/2023	9,699	0.0%	138,771	9/30/2023
2023 Q2	8/10/2023	10,041	0.0%	139,732	6/30/2023
2023 Q1	5/9/2023	8,357	0.0%	135,491	3/31/2023
2022 Q4	2/13/2023	10,705	0.0%	138,792	12/31/2022
2022 Q3	10/27/2022	6,711	0.0%	150,406	9/30/2022
2022 Q2	8/1/2022	10,068	0.0%	262,882	6/30/2022
2022 Q1	5/11/2022	80	0.0%	1,938	3/31/2022
2021 Q4	2/11/2022	411	0.0%	10,876	12/31/2021
2021 Q3	11/10/2021	366	0.0%	11,100	9/30/2021
2021 Q2	8/5/2021	641	0.0%	9,510	6/30/2021
2021 Q1	4/28/2021	531	0.0%	9,374	3/31/2021
2020 Q4	2/4/2021	738	0.0%	9,061	12/31/2020
2020 Q3	11/10/2020	601	0.0%	8,431	9/30/2020
2020 Q2	8/7/2020	226	0.0%	2,753	6/30/2020
2020 Q1	5/13/2020	183	0.0%	3,104	3/31/2020
2019 Q4	2/4/2020	191	0.0%	1,846	12/31/2019